DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile-Reference-Cited by-同舟云学术

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

Published:2019-12 Issue: Volume:138 Page:102-108
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Hermans B.C.M.^ORCID,Derks J.L.^ORCID,Thunnissen E.,van Suylen R.J.,den Bakker M.A.,Groen H.J.M.,Smit E.F.,Damhuis R.A.,van den Broek E.C.,Ruland A.,Speel E.J.M.,Dingemans A.M.C.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference37 articles.

1. Clinical features of large cell neuroendocrine carcinoma: a population-based overview;Derks;Eur. Respir. J.,2016

2. Neuroendocrine neoplasms of the lung: a prognostic spectrum;Asamura;J. Clin. Oncol.,2006

3. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung;Rossi;J. Clin. Oncol.,2005

4. American society of clinical oncology clinical, systemic therapy for stage IV non-small-Cell lung Cancer: american society of clinical oncology clinical practice guideline update;Masters;J. Clin. Oncol.,2015

5. A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo;Saunders;Sci. Transl. Med.,2015

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications;Modern Pathology;2024-10

2. Tarlatamab for Large Cell Neuroendocrine Carcinoma in a Young Adult: A Case Report;JTO Clinical and Research Reports;2024-10

3. Advances in genetic profile and therapeutic strategy of pulmonary large cell neuroendocrine carcinoma;Frontiers in Medicine;2024-02-27

4. Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites;Cancer Cell;2023-12

5. Subtype of SCLC Is an Intrinsic and Persistent Feature Through Systemic Treatment;JTO Clinical and Research Reports;2023-09